Shunsuke Tanigawa

Title: Shunsuke Tanigawa: Innovator in Wnt Pathway Research

Introduction

Shunsuke Tanigawa is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of biomedical research, particularly in the area of synthetic peptide inhibitors of the Wnt pathway. His innovative work has the potential to impact various diseases mediated by this critical signaling pathway.

Latest Patents

Tanigawa holds a patent for "Synthetic peptide inhibitors of Wnt pathway." This patent describes a peptide or peptidomimetic that comprises the amino acid sequence KKRLSVXLTSSLFR (SEQ ID NO: 1) or its inverse. It also includes at least eight contiguous amino acids of helix C of β-catenin (SEQ ID NO: 41) or its inverse. The invention focuses on peptides or peptidomimetics that contain about 50 or fewer amino acids and inhibit the Wnt pathway. Additionally, it outlines methods for inhibiting the Wnt pathway in a cell and treating or preventing diseases mediated by this pathway.

Career Highlights

Tanigawa is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work in this esteemed organization highlights his commitment to advancing health-related research and innovation.

Collaborations

Some of his notable coworkers include Nadya Tarasova and Alan O Perantoni. Their collaborative efforts contribute to the ongoing research and development in the field of peptide inhibitors.

Conclusion

Shunsuke Tanigawa's innovative research in synthetic peptide inhibitors of the Wnt pathway showcases his dedication to advancing biomedical science. His contributions have the potential to lead to significant advancements in the treatment of diseases associated with this pathway.